Laboratory products
Worldwide Support for Virology Research Announced
Apr 28 2020
In the current urgency to develop vaccines against virus-related diseases, academic institutes and biopharmaceutical companies worldwide rely on the broad product portfolio offered by ibidi. Many publications in reputable scientific journals reflect the importance of ibidi’s ongoing contribution to this research area.
The COVID-19 pandemic, caused by the highly pathogenic SARS-CoV-2 virus, is spreading quickly. Scientists all over the world are intensively working to find solutions to fight this and other viruses - from pathogen detection through therapeutics, to the development of novel vaccines.
For more than 18 years, ibidi has been helping in many areas of virology research, resulting in hundreds of virology-related publications citing ibidi solutions. Researchers can refer to the ibidi Publication Database at ibidi.com to find references for their specific scientific work.
“The research of specific antiviral treatments is urgently needed, and we are working hard to help researchers worldwide advance their therapeutic solutions,” said Dr Roman Zantl, CEO at ibidi. “If you need a specialised product for your research that is not in our portfolio, please contact us and we will gladly collaborate with you.”
More information online
Digital Edition
ILM 50.3 April 2025
May 2025
Chromatography Articles - Optimising two-step purification: Key considerations for sample pump setups Mass Spectrometry & Spectroscopy Articles - Detecting pharmaceuticals and their transf...
View all digital editions
Events
May 27 2025 Basel, Switzerland
Jun 01 2025 Baltimore, MD, USA
Jun 04 2025 Koeln, Germany
Jun 11 2025 Bangkok, Thailand
Jun 15 2025 Bruges, Belgium